Viracta Therapeutics
VIRX
#10169
Rank
NZ$11.43 M
Marketcap
$0.29
Share price
-2.16%
Change (1 day)
-63.60%
Change (1 year)

Market capitalization of Viracta Therapeutics (VIRX)

Market cap: NZ$11.43 Million

As of January 2025 Viracta Therapeutics has a market cap of NZ$11.43 Million. This makes Viracta Therapeutics the world's 10169th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Viracta Therapeutics from 2021 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$11.43 M1.39%
2024NZ$11.27 M-67.61%
2023NZ$34.81 M-60.37%
2022NZ$87.83 M-56.08%
2021NZ$0.19 B

End of Day market cap according to different sources

On Jan 22nd, 2025 the market cap of Viracta Therapeutics was reported to be:

NZ$11.43 Million
by Nasdaq info icon info icon
NZ$11.43 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$1.22 B 10,644.62%๐Ÿ‡บ๐Ÿ‡ธ USA